These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Hadinoto K; Sundaresan A; Cheow WS Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180 [TBL] [Abstract][Full Text] [Related]
3. Nanotechnology applied to the treatment of malaria. Santos-Magalhães NS; Mosqueira VC Adv Drug Deliv Rev; 2010 Mar; 62(4-5):560-75. PubMed ID: 19914313 [TBL] [Abstract][Full Text] [Related]
4. Role of integrated cancer nanomedicine in overcoming drug resistance. Iyer AK; Singh A; Ganta S; Amiji MM Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506 [TBL] [Abstract][Full Text] [Related]
5. Sirolimus-loaded stealth colloidal systems attenuate neointimal hyperplasia after balloon injury: a comparison of phospholipid micelles and liposomes. Haeri A; Sadeghian S; Rabbani S; Anvari MS; Lavasanifar A; Amini M; Dadashzadeh S Int J Pharm; 2013 Oct; 455(1-2):320-30. PubMed ID: 23867987 [TBL] [Abstract][Full Text] [Related]
6. Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids. Maherani B; Arab-Tehrany E; Kheirolomoom A; Geny D; Linder M Biochimie; 2013 Nov; 95(11):2018-33. PubMed ID: 23871914 [TBL] [Abstract][Full Text] [Related]
7. The helical propensity of KLA amphipathic peptides enhances their binding to gel-state lipid membranes. Arouri A; Dathe M; Blume A Biophys Chem; 2013; 180-181():10-21. PubMed ID: 23792704 [TBL] [Abstract][Full Text] [Related]
8. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) -- structural investigations on two different carrier systems. Saupe A; Wissing SA; Lenk A; Schmidt C; Müller RH Biomed Mater Eng; 2005; 15(5):393-402. PubMed ID: 16179760 [TBL] [Abstract][Full Text] [Related]
10. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes. Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245 [TBL] [Abstract][Full Text] [Related]
11. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. Jores K; Mehnert W; Drechsler M; Bunjes H; Johann C; Mäder K J Control Release; 2004 Mar; 95(2):217-27. PubMed ID: 14980770 [TBL] [Abstract][Full Text] [Related]
12. Properties of various phospholipid mixtures as emulsifiers or dispersing agents in nanoparticle drug carrier preparations. Ishii F; Nii T Colloids Surf B Biointerfaces; 2005 Apr; 41(4):257-62. PubMed ID: 15748821 [TBL] [Abstract][Full Text] [Related]
14. Kanamycin incorporation in lipid vesicles prepared by ethanol injection designed for tuberculosis treatment. Justo OR; Moraes AM J Pharm Pharmacol; 2005 Jan; 57(1):23-30. PubMed ID: 15638989 [TBL] [Abstract][Full Text] [Related]
15. Stearylamine Liposomal Delivery of Monensin in Combination with Free Artemisinin Eliminates Blood Stages of Plasmodium falciparum in Culture and P. berghei Infection in Murine Malaria. Rajendran V; Rohra S; Raza M; Hasan GM; Dutt S; Ghosh PC Antimicrob Agents Chemother; 2015 Dec; 60(3):1304-18. PubMed ID: 26666937 [TBL] [Abstract][Full Text] [Related]
16. A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: From liposomal preparation to therapy. Farzaneh H; Ebrahimi Nik M; Mashreghi M; Saberi Z; Jaafari MR; Teymouri M Int J Pharm; 2018 Nov; 551(1-2):300-308. PubMed ID: 30243944 [TBL] [Abstract][Full Text] [Related]
17. Use of poly(amidoamine) drug conjugates for the delivery of antimalarials to Plasmodium. Urbán P; Valle-Delgado JJ; Mauro N; Marques J; Manfredi A; Rottmann M; Ranucci E; Ferruti P; Fernàndez-Busquets X J Control Release; 2014 Mar; 177():84-95. PubMed ID: 24412735 [TBL] [Abstract][Full Text] [Related]
18. Effect of a cholesterol-rich lipid environment on the enzymatic activity of reconstituted hyaluronan synthase. Ontong P; Hatada Y; Taniguchi S; Kakizaki I; Itano N Biochem Biophys Res Commun; 2014 Jan; 443(2):666-71. PubMed ID: 24333423 [TBL] [Abstract][Full Text] [Related]
19. Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles. Date AA; Joshi MD; Patravale VB Adv Drug Deliv Rev; 2007 Jul; 59(6):505-21. PubMed ID: 17574295 [TBL] [Abstract][Full Text] [Related]
20. 2-Dioleoyl-sn-glycero-3-phosphocholine-based nanoliposomes as an effective delivery platform for 17β-estradiol. Bowey K; Tanguay JF; Tabrizian M Eur J Pharm Biopharm; 2014 Apr; 86(3):369-75. PubMed ID: 24161656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]